International reference: 2 US FDA recalls for this ingredient

Lack of Assurance of Sterility: Complaints of syringe breakage (aflibercept)

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared. (aflibercept)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in Uganda.

Registered Uganda · NDA

AFLIBERCEPT

NDA/MAL/HDP/9779 PARENTERAL ORDINARY VIALS 40 MG/ML

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
NDA/MAL/HDP/9779
Registration date
05/10/2021
Expiry date
-
Status
Registered
Active ingredient
-
Dosage form
PARENTERAL ORDINARY VIALS
Strength
40 MG/ML
Pack size
1.0X1.0 ML VIAL
Therapeutic class
-
Manufacturer / MAH
Bayer Ag, Berlin, Mullerstrabe 178
Applicant / LTR
BAYER EAST AFRICA LTD
Country of origin
GERMANY
Manufacturer location
Müllerstraße 178, 13353 Berlin, Germany

Source: National Drug Authority · fetched 2026-04-21 17:37:11 · updated 2026-09-12 04:00:21

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.